These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 33187907)
1. Overexpression of B7-H4 is associated with infiltrating immune cells and poor prognosis in metastatic colorectal cancer. Ding S; Lv X; Liu Z; Zhan S; Xu Y; Zhang X; Liu C; Cao L Int Immunopharmacol; 2021 Jan; 90():107144. PubMed ID: 33187907 [TBL] [Abstract][Full Text] [Related]
2. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness. Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases. Qian Y; Sang Y; Wang FX; Hong B; Wang Q; Zhou X; Weng T; Wu Z; Zheng M; Zhang H; Yao H Oncotarget; 2016 Nov; 7(44):72242-72249. PubMed ID: 27750217 [TBL] [Abstract][Full Text] [Related]
4. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer. Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225 [TBL] [Abstract][Full Text] [Related]
5. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer. Si S; Wang L; Cao H; Xu Y; Zhan Q BMC Cancer; 2022 Feb; 22(1):211. PubMed ID: 35219310 [TBL] [Abstract][Full Text] [Related]
6. Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma. Mizuno T; Kamai T; Tsuzuki T; Nishihara D; Kijima T; Arai K; Yoshida KI Cancer Immunol Immunother; 2022 Mar; 71(3):565-578. PubMed ID: 34275008 [TBL] [Abstract][Full Text] [Related]
7. B7 family member H4 induces epithelial-mesenchymal transition and promotes the proliferation, migration and invasion of colorectal cancer cells. Yin Y; Shi L; Yang J; Wang H; Yang H; Wang Q Bioengineered; 2022 Jan; 13(1):107-118. PubMed ID: 34818980 [TBL] [Abstract][Full Text] [Related]
8. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration. Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer. Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517 [TBL] [Abstract][Full Text] [Related]
10. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer. Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889 [TBL] [Abstract][Full Text] [Related]
11. B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition. Yan X; Hong B; Feng J; Jin Y; Chen M; Li F; Qian Y BMC Cancer; 2022 Oct; 22(1):1053. PubMed ID: 36217128 [TBL] [Abstract][Full Text] [Related]
12. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Chen LJ; Sun J; Wu HY; Zhou SM; Tan Y; Tan M; Shan BE; Lu BF; Zhang XG Cancer Immunol Immunother; 2011 Jul; 60(7):1047-55. PubMed ID: 21519829 [TBL] [Abstract][Full Text] [Related]
13. B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma. Lu Z; Zhao ZX; Cheng P; Huang F; Guan X; Zhang MG; Chen HP; Liu Z; Jiang Z; Zheng ZX; Zou SM; Wang XS Mod Pathol; 2020 Nov; 33(11):2330-2340. PubMed ID: 32514163 [TBL] [Abstract][Full Text] [Related]
14. T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province. Liang M; Li J; Wang D; Li S; Sun Y; Sun T; Zhang J; Chen X; Li Q; Sun S Tumour Biol; 2014 Jan; 35(1):55-60. PubMed ID: 23873101 [TBL] [Abstract][Full Text] [Related]
15. Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas. Niu N; Shen W; Zhong Y; Bast RC; Jazaeri A; Sood AK; Liu J Hum Pathol; 2021 Jul; 113():20-27. PubMed ID: 33887301 [TBL] [Abstract][Full Text] [Related]
16. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells. Miao G; Sun X Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096 [TBL] [Abstract][Full Text] [Related]
17. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis. Guo L; Liu Z; Zhang Y; Quan Q; Huang L; Xu Y; Cao L; Zhang X Medicine (Baltimore); 2019 Feb; 98(8):e14663. PubMed ID: 30813210 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma. Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma. Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470 [TBL] [Abstract][Full Text] [Related]
20. Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance. Geng Y; Wang H; Lu C; Li Q; Xu B; Jiang J; Wu C Int J Clin Oncol; 2015 Apr; 20(2):273-81. PubMed ID: 24804867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]